Introduction
Every medicine has a profile of expected benefits and potential risks. A therapeutic benefit is a favorable health outcome associated with treatment, whereas a risk is the possibility of an unwanted or harmful outcome. Responsible pharmacological evaluation considers both sides rather than judging a medicine solely by its intended action.
Therapeutic benefits
Definition
Therapeutic benefits are favorable effects of a medicine that contribute to the prevention, treatment, control, or management of a health condition.
Major categories
| Category | Description |
|---|---|
Symptom improvement | Reduction in the severity or frequency of symptoms. |
Disease control | Reduction or stabilization of disease activity. |
Disease prevention | Reduction in the likelihood of a specified disease or complication. |
Functional improvement | Improvement in physical, physiological, or cognitive functioning when supported by evidence. |
Survival benefit | Reduction in mortality risk in clinical situations where a treatment has demonstrated this outcome. |
Quality-of-life improvement | Improvement in relevant aspects of daily functioning and well-being. |
Potential risks
Definition
Potential risks are possible unwanted outcomes associated with exposure to a medicine under particular conditions.
Major categories
| Category | Description |
|---|---|
Adverse drug reactions | Harmful or unintended responses associated with medicinal use. |
Allergic and hypersensitivity reactions | Immune-mediated or allergy-like responses to a medicine or its components. |
Drug interactions | Changes in the effects or exposure of medicines caused by interactions with other drugs or substances. |
Contraindication-related risks | Risks that arise when a medicine is unsuitable for a particular medical condition or clinical situation. |
Organ toxicity | Potential harmful effects on organs such as the liver, kidneys, heart, or nervous system. |
Treatment failure | Failure to achieve the intended clinical outcome despite treatment. |
Uncertain or delayed effects | Potential outcomes that may not be fully recognized until additional evidence or longer follow-up becomes available. |
Benefit risk assessment
Definition
Benefit-risk assessment is the structured evaluation of the expected therapeutic benefits of a medicine in relation to its known and potential risks.
Major considerations
Severity and likelihood of the condition being treated.
Magnitude and certainty of expected therapeutic benefit.
Frequency, severity, and reversibility of adverse effects.
Availability of alternative treatments.
Patient characteristics and relevant medical conditions.
Quality and limitations of available scientific evidence.
Duration and context of treatment.
Patient preferences and treatment goals.
Important principle
The acceptability of a medicine's risk profile depends on its intended use and clinical context. A level of risk that may be acceptable for a severe or life-threatening condition may not be acceptable for a minor condition.
Risk characterization
| Factor | Description |
|---|---|
Probability | How likely an adverse outcome is to occur. |
Severity | How serious the consequences of an adverse outcome may be. |
Duration | How long an adverse effect may continue. |
Reversibility | Whether the effect is expected to resolve after the relevant exposure ends or treatment is changed. |
Uncertainty | How incomplete the available information is about the frequency or consequences of a potential harm. |
Risk reduction principles
Use medicines for evidence-supported indications.
Consider relevant contraindications and interactions.
Evaluate patient-specific risk factors.
Follow authorized product information and professional guidance.
Monitor treatment outcomes and relevant safety indicators.
Report suspected adverse drug reactions through appropriate systems.
Reassess treatment when new evidence or clinically important changes arise.
Population and individual context
The balance between benefits and risks can differ among individuals and populations. Age, genetics, pregnancy status, organ function, coexisting diseases, other medicines, and the severity of the condition may change the expected outcome. Population-level evidence therefore needs to be interpreted in the context of individual clinical circumstances.
Common misconceptions
| Misconception | Correction |
|---|---|
An approved medicine has no risks. | Authorization indicates that a medicine has met applicable regulatory requirements for specified uses; it does not mean that adverse effects are impossible. |
Any adverse effect means that a medicine has no therapeutic value. | A medicine can provide important benefits while also having risks that must be assessed and managed. |
The same benefit-risk balance applies to every patient. | The balance can differ according to patient characteristics, disease severity, and available alternatives. |